EXAS – exact sciences corporation (US:NASDAQ)
Stock Stats
News
Exact Sciences to Participate in J.P. Morgan Healthcare Conference
Exact Sciences Co. (NASDAQ: EXAS) had its price target lowered by analysts at Bank of America Co. from $75.00 to $72.00. They now have a "buy" rating on the stock.
Bladder Cancer Detection Kit Market to Hit USD 2.99 Billion by 2032, Driven by Advancements in Non-Invasive Technologies | Research by SNS Insider [Yahoo! Finance]
AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates [Yahoo! Finance]
Exploring High Growth Tech Stocks in December 2024 [Yahoo! Finance]
Form 4 EXACT SCIENCES CORP For: Jan 02 Filed by: Popovits Kimberly J
Form 3 EXACT SCIENCES CORP For: Jan 02 Filed by: Popovits Kimberly J
Form 8-K EXACT SCIENCES CORP For: Jan 02
Form 4/A EXACT SCIENCES CORP For: Jun 13 Filed by: Zanotti Katherine S
Form 4/A EXACT SCIENCES CORP For: Jun 13 Filed by: Clancy Paul J
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.